Clinical Trial

Study on Biomarkers of Immune-Related Adverse Events

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
1. To identify biomarkers of immune-related adverse events; 2. To develop a predictive model for immune-related adverse events.
Trial Details
NCT Number NCT07527585
Lead Sponsor Huazhong University of Science and Technology
Conditions Immune-Related Adverse Events
Enrollment 440 participants
Start Date 2026-04
Primary Completion 2032-12 (estimated)
Study Completion 2032-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-14